Lieff Cabraser Civil Justice Blog
FDA Warning: Antipsychotic Drug Abilify Linked to Severe Compulsive Behavior and Addiction

FDA Warning: Antipsychotic Drug Abilify Linked to Severe Compulsive Behavior and Addiction

The Food and Drug Administration (FDA) has issued a formal warning that the use of the antipsychotic drug aripiprazole (Abilify, Abilify Maintena, Aristada, and also used in generic versions of the drug) has been linked to compulsive urges, which can lead to uncontrollable gambling, among other addictions. These rare but serious impulse-control problems reportedly stop when the medicine is discontinued or markedly reduced in dosage.

Aripiprazole is prescribed to treat mental disorders including depression and schizophrenia. Abilify is Bristol-Myers Squibb’s top-selling drug, earning the company $6.4 billion in 2013. Indeed, Abilify was the number one most profitable drug in the country. More than 8.8 million Abilify prescriptions were written in 2014 alone, according to Medscape.

Abilify was the first aripiprazaole product – the drug was approved in November 2002. However, since the drug’s approval through mid-January 2016, there were 184 case reports in the FDA Adverse Event Reporting System and other medical literature which indicated that the antipsychotic drug was associated with significant impulse-control problems.

Abilify patients have filed lawsuits against Abilify manufacturer Bristol-Myers Squibb alleging that the drug has been linked to damaging impulsive behavior in users who previously had no history of such conduct. In particular, the pathological gambling addiction can be so severe that patients go into extreme debt and even lose their homes. While Bristol-Myers does mention the risk of compulsive behavior on Abilify’s drug label, this description “does not entirely reflect the nature of the impulse-control risk,” according to the FDA.

Contact a Drug Injury Attorney

Abilify users who suffered extreme and debilitating debt from their Abilify-linked gambling addictions can file lawsuits against Abilify’s manufacturer to recover their losses and seek help with their ruinous debts and related psychological distress. If you or a family member suffered losses from compulsive and excessive gambling you think may be linked to Abilify use, Lieff Cabraser welcomes the chance to talk with you. In addition to potentially helping you with your Abilify related losses, learning of your experience can help others suffering from Abilify’s depravations. Learn more about the Abilify Gambling Addiction Lawsuits.